Owner/Developer: Selvita S.A.
Selvita is a drug discovery company engaged in the research and development of breakthrough therapies primarily in the area of oncology, as well as provision of integrated drug discovery services. The company was established in 2007 and currently employs over 340 scientists, among which 30% are PhDs. Selvita offers integrated drug discovery projects helping biotech and pharma partners discover and develop new drugs. Our scientists have an extensive experience in several areas of life sciences. Selvita specializes in a broad spectrum of pharmacodynamic in vitro studies used to analyze biosimilar product's activity in comparison to adequate reference compounds. We offer assays that are able to detect even minor changes in biological response to pharmacologically active substances. EU-NETVAL member.
|Channel:||Website - Audio / Video - Social media - Professional online network|
|Relevance:||Replacement - Reduction|
|Purpose:||Fundamental studies - Toxicological and safety evaluation - Efficacy testing - Regulatory testing - Validation - Method development|
|Technology/Tools:||High throughput screening - Non-testing methods (in silico) - Omics - Alternative test methods (in vitro)|
Did you find what you were looking for?Yes, I found it! No, I did not!
Thanks for your feedback! Please note that we cannot respond unless you supply your email address.
What are you looking for?
Please give us your feedback so we can improve the information on the page. Thank you in advance for your help. Please add your email address if you would like a reply.Please contact us by email if you have any questions.